ARTICLE | Company News
AIT Strategies, Quest Pharma, Stanford University deal
November 18, 2013 8:00 AM UTC
Quest PharmaTech received an exclusive license from the university to develop and commercialize anti- mucin 1 ( MUC1; CD227) IgE technology. The university will receive an upfront payment, annual mai...